Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng Jin

Showing results (761-770 of 778) with videos related to

Pageof 78
Sort By:
Gene|January 1, 2018
Regulatory variants in cancer-related pathway genes predict survival of patients with surgically resected non-small cell lung cancerKyung Min Shin, Mi Jeong Hong, Shin Yup Lee, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 29, 2025
A Novel Self-Regulated, Non-Directional Magnetic Thermos-Brachytherapy <sup>125</sup>I Seed Enhances Anticancer Efficacy by Rescuing Immune EscapeBin Xu, Ye-Ming Wu, Yi-Fei Cheng, et al.
International Journal of Surgery (London, England)|December 11, 2025
125I stent plus combination therapy for HCC and portal vein tumor thrombosis: a nationwide target trial emulationJun-Hao Mei, Kai-Zhi Jia, Kai Zhang, et al.
Scientific Reports|October 22, 2016
Genetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancerShin Yup Lee, Cheng Cheng Jin, Jin Eun Choi, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Autonomous AI Agents Discover Aging Interventions from Millions of Molecular ProfilesKejun Ying, Alexander Tyshkovskiy, Alibek Moldakozhayev, et al.
Alimentary Pharmacology & Therapeutics|March 31, 2026
Camrelizumab and Apatinib With or Without Transarterial Chemoembolisation as First-Line Treatment for Advanced Hepatocellular Carcinoma (CHANCE2311)Rong Ding, Jin-Feng Bai, Zhi-Cheng Jin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2026
Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II TrialHai-Dong Zhu, Wei-Jun Fan, Chang Zhao, et al.
Science Translational Medicine|April 1, 2026
Site-specific methylation of SRSF2<sup>P95H</sup> by SETD2 inhibits MDSC-mediated proinflammatory niche formation in mouse models of myelodysplastic syndromeZi-Juan Li, Mu-Ying Zhao, Roujia Wang, et al.
Cancer Discovery|April 29, 2025
Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung CancerEverett J Moding, Mohammad Shahrokh Esfahani, Cheng Jin, et al.
Eclinicalmedicine|February 18, 2026
Transarterial chemoembolization (TACE) combined with immunotherapy and anti-angiogenic agents in intermediate-stage hepatocellular carcinoma (CHANCE2202): a target trial emulation studyJian-Jian Chen, Zhi-Cheng Jin, Jia-Wei Zhou, et al.
Pageof 78

Showing results (761-770 of 778) with videos related to

Sort By:
Pageof 78
Gene|January 1, 2018
Regulatory variants in cancer-related pathway genes predict survival of patients with surgically resected non-small cell lung cancerKyung Min Shin, Mi Jeong Hong, Shin Yup Lee, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 29, 2025
A Novel Self-Regulated, Non-Directional Magnetic Thermos-Brachytherapy <sup>125</sup>I Seed Enhances Anticancer Efficacy by Rescuing Immune EscapeBin Xu, Ye-Ming Wu, Yi-Fei Cheng, et al.
International Journal of Surgery (London, England)|December 11, 2025
125I stent plus combination therapy for HCC and portal vein tumor thrombosis: a nationwide target trial emulationJun-Hao Mei, Kai-Zhi Jia, Kai Zhang, et al.
Scientific Reports|October 22, 2016
Genetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancerShin Yup Lee, Cheng Cheng Jin, Jin Eun Choi, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Autonomous AI Agents Discover Aging Interventions from Millions of Molecular ProfilesKejun Ying, Alexander Tyshkovskiy, Alibek Moldakozhayev, et al.
Alimentary Pharmacology & Therapeutics|March 31, 2026
Camrelizumab and Apatinib With or Without Transarterial Chemoembolisation as First-Line Treatment for Advanced Hepatocellular Carcinoma (CHANCE2311)Rong Ding, Jin-Feng Bai, Zhi-Cheng Jin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2026
Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II TrialHai-Dong Zhu, Wei-Jun Fan, Chang Zhao, et al.
Science Translational Medicine|April 1, 2026
Site-specific methylation of SRSF2<sup>P95H</sup> by SETD2 inhibits MDSC-mediated proinflammatory niche formation in mouse models of myelodysplastic syndromeZi-Juan Li, Mu-Ying Zhao, Roujia Wang, et al.
Cancer Discovery|April 29, 2025
Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung CancerEverett J Moding, Mohammad Shahrokh Esfahani, Cheng Jin, et al.
Eclinicalmedicine|February 18, 2026
Transarterial chemoembolization (TACE) combined with immunotherapy and anti-angiogenic agents in intermediate-stage hepatocellular carcinoma (CHANCE2202): a target trial emulation studyJian-Jian Chen, Zhi-Cheng Jin, Jia-Wei Zhou, et al.
Pageof 78